drugset / Trial / NCT06360133
Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 3, randomized, double-Masked, vehicle-controlled, multi-center study designed to evaluate the safety and efficacy of 5% VVN001 Ophthalmic Solution versus vehicle in Chinese subjects with dry eye disease.
Timeline
- Start
- 2024-04-01
- Primary completion
- 2026-03-31
- Completion
- 2026-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VVN001 | Small molecule | 5 % | — |